Introduction: Sarcopenia, which is defined as loss of skeletal muscle mass and strength, affects up to 70% of patients with liver cirrhosis. Since hibernating animals maintain muscle mass through ...

Abstract: Graph neural networks (GNNs), as a cutting-edge technology in deep learning, perform particularly well in various tasks that process graph structure data. However, their foundation on ...

Structure Therapeutics (GPCR) just moved its obesity pipeline up a gear by kicking off a first in human Phase 1 trial for ACCG-2671, its oral amylin receptor agonist targeting metabolic disease. See ...